Journal of Organic Chemistry p. 1335 - 1343 (1982)
Update date:2022-08-25
Topics:
Kuehne, Martin E.
Okuniewicz, J. F.
Kirkemo, C. L.
Bohnert, J. C.
Condensation of methyl 1,2,3,4,5,6-hexahydroazepino<4,5-b>indole-5-carboxylate (6) with 5-chloro-2-ethyl-4-hydroxypentanal lactol (14) yielded the 14α- and 14β-hydroxyvincadifformines (8a,b) in an epimeric ratio which was solvent dependent.On condensation of the indoloazepine 6 with 4,5-epoxy-2-ethylpentanal (9) the same compounds were formed together wih a (hydroxymethyl)-D-norvincadifformine, 10, as the major product.Dehydration of 14β-hydroxyvincadifformine (8a) readily gave tabersonine (1), while 14α-hydroxyvincadifformine (8b) could only be dehydrated bycarbamate pyrolysis.The latter compound (8b) and the (hydroxymethyl)-D-norvincadifformine 10 could be converted to vincadifformine (18) through the chloromethyl derivative 16.Condensation of the indoloazepine 6 with the epimeric 4,5-dichloro-2-ethylpentanals (19) also gave the (chloromethyl)-D-norvincadifformine 16 and 14β-chlorvinacadifformine (20).Dehydrohalogenation of the latter compound provided a third sequence to tabersonine (1).A synthesis of the C-20 epimeric pandolines (2a,b) from 5-chloro-4-ethyl-4-hydroxypentanal lactol (22) similarly allowed control of the C-20 epimeric product ratio through its solvent dependence.
View MoreSuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Improve Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Hefei Highzone Fine Chemical S&T CO.,LTD
Contact:86-0551-63663560
Address:room 1801 NO. 24 Shuguang RD.
Doi:10.1016/S0040-4039(03)01534-X
(2003)Doi:10.1039/P29750000825
(1975)Doi:10.1039/j39690000173
(1969)Doi:10.1021/acs.joc.5b01517
(2015)Doi:10.3987/COM-05-10609
(2006)Doi:10.1021/om990649g
(1999)